Medical/Pharmaceuticals
NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered inItaly, presents positive results from Phase II MIRAKLE study, a multicentre, randomized, blinded-assessor, phase II non-inferiority study evaluatingthe efficacy and tolerability of NTC014 ...
2024-12-05 19:00
1342
Cao Thang International Eye Hospital - Marking a footprint on the map of global ophthalmology
HO CHI MINH CITY, Vietnam, Dec. 5, 2024 /PRNewswire/ -- On November 10, 2024, Cao Thang International Eye Hospital was proudly certified to be an official membership with the World Association of Eye Hospitals (WAEH) at the 18th annual meeting which was held inChina. Cao Thang International Eye ...
2024-12-05 18:35
1822
CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial
MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers (DFU). Key...
2024-12-05 11:59
1463
Former CSL CEO Paul Perreault appointed strategic adviser to Microbio
Establishing sepsis diagnostic InfectID™ as the new standard of care BRISBANE, Australia, Dec. 5, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has today announced the appointment ofPaul Perreault as a st...
2024-12-05 06:30
1660
LBB Specialties and Clariant Partner to Distribute High-Quality Pharmaceutical Grade PEGs for Ophthalmic Applications
NORWALK, Conn., Dec. 5, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, announced a strategic partnership with Clariant, a global leader in specialty chemical manufacturing. Through this collaboration, LBB Specialties will ...
2024-12-05 04:02
1298
CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms
HONG KONG, Dec. 4, 2024 /PRNewswire/ -- The Chinese University of Hong Kong's Faculty of Medicine (CU Medicine) has, for the first time, discovered novel microbial signatures associated with inflammation of the gastrointestinal (GI) tract and transformed such signatures into clinically applicable...
2024-12-04 22:26
1706
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter
AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to use an all-in-one high-density mapping and dual energy ablation catheter for the treatment of persistent atria...
2024-12-04 10:07
1432
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
* Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission. * In the high dose cohort, 6 out of 7 (85.7%) patients achieved overall clinical remission and ...
2024-12-04 09:10
2045
Exciting Offers Await at the 2024 Hong Kong Brands and Products Expo: Herbalgy Presents Exclusive Deals & Debuting "Yick Kee Balanced Tea Limited" Health Tea Bags!
Exclusive Discounts Up to 38% and Limited Edition Gifts HONG KONG, Dec. 4, 2024 /PRNewswire/ -- As December approaches, the highly anticipated Hong Kong Brands and Products Expo is just around the corner. Herbalgy Pharmaceutical Limited, a proud participant in this annual shopping event for many...
2024-12-04 09:00
1729
Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer
SAN FRANCISCO, U.S. and SUZHOU, China, Dec. 4, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...
2024-12-04 08:00
2006
Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia
After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions, this significant milestone further strengthens the company's long-term expansion strategy in the region. This is also reinforced by the recent launch of the FMD vaccine, Bioaftogen, i...
2024-12-03 23:34
1595
ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
First Implants of Innovative Device Completed in the United States and Australia MINNEAPOLIS, Dec. 3, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage innovator in neuromodulation technology, today announced the initiation of its U.S. Food and Drug Administration (FDA)-approved Investigation D...
2024-12-03 23:07
1168
Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, ...
2024-12-03 22:00
1219
A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve the way AF is treated. PRAGUE, Dec. 3, 2024 /PRNewswi...
2024-12-03 21:00
1122
AC Health makes critical HIV care more accessible to Filipinos with USAID support
MANILA, Philippines, Dec. 3, 2024 /PRNewswire/ -- Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector's efforts to fight the HIV epidemic inthe Philippines by improving access to stigma-free care and...
2024-12-03 16:11
4466
ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS "Gold Standard" Technology to Safeguard the Visual Health of Children and Adolescents
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Global optical technology leader ZEISS debuted the ZEISS MYO 200 Biometer for Myopia Management inHong Kong on November 28th, to provide more precise myopia control and improved visual health for children and adolescents. Specifically tailored for children ...
2024-12-03 15:13
2009
Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
* In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypesleading to most of the invasive pneumococcal diseases and pneumonia[i],[ii] – is now approved fo...
2024-12-03 15:08
1762
Fosun's Rural Doctors Program Recognized in UNGC's "20 Cases of Private Sector's Sustainable Development in China for 20 Years" Report
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- This year marks the 20th anniversary of the United Nations Global Compact ("UNGC")'s introduction of Environmental, Social, and Governance (ESG) concept and principles. On29 November 2024, the UNGC held a launch event for the "20 Cases of Private Sector's S...
2024-12-03 11:47
1615
Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024
CHICAGO, Dec. 3, 2024 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical Systems"), a global leader in medical imaging solutions and services, is proud to announce its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting, taking place in Chicago fr...
2024-12-03 09:50
1588
ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority
Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 3, 2024 /PRNewswire/ -- MatOrtho, the UK-based global innovator of hip and knee replacement devices, today announced that the ReCerf® Hip Resurfacing Arthroplasty has become the world's first all-ceramic hip ...
2024-12-03 00:08
1473
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 305 media titles]
2024-12-19 17:56
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 304 media titles]
2024-12-20 16:25
ADA Acquires Customore, Launching the Most Advanced Intelligent Commerce Solution for the CPG Industry
[Picked up by 296 media titles]
2024-12-17 11:00
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 295 media titles]
2024-12-20 18:11
Most Read
ADA Acquires Customore, Launching the Most Advanced Intelligent Commerce Solution for the CPG Industry
2024-12-17 11:00
4099
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
3902
Dhaka Court Dismisses Allegations Against Nagad Founder Tanvir A Mishuk
2024-12-16 18:32
3811
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
2024-12-19 13:41
3624
HUAWEI FreeBuds Pro 4: HUAWEI SOUND Elevating TWS Flagship Experience to New Heights
2024-12-15 00:04
3541
